Literature DB >> 19879885

Inhibition impairments in Alzheimer's disease, mild cognitive impairment and healthy aging: effect of congruency proportion in a Stroop task.

Sara Bélanger1, Sylvie Belleville, Serge Gauthier.   

Abstract

The goal of this study was to assess inhibition and goal maintenance in persons with Alzheimer's disease, mild cognitive impairment, healthy older adults and younger adults. This was done by using a task that compared the Stroop effect in pure blocks, that comprised only incongruent trials, with the Stroop effect in mixed blocks, in which 25% of trials were incongruent and 75% were congruent (Kane & Engle, 2003). Those conditions were administered to 20 healthy younger and 20 older control participants, and to 20 participants meeting criteria for MCI and 11 for AD. Results show reduced resistance to interference as a consequence of healthy aging and only partially impaired goal-maintenance capacities. Interference and goal maintenance are also impaired when comparing MCI and AD to healthy older adults, with AD suffering from a more severe impairment than MCI. In addition, there is a partial preservation of goal-maintenance capacities in MCI because reducing response speed allows them to maintain a level of error rate similar to that of healthy older adults. In contrast, AD persons suffer from a complete breakdown of goal-maintenance capacities, as is suggested by deficits on both response time and error rates. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19879885     DOI: 10.1016/j.neuropsychologia.2009.10.021

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  35 in total

1.  Cognitive demand does not influence the responsiveness of homonymous Ia afferents pathway during postural dual task in young and elderly adults.

Authors:  Stéphane Baudry; Vinciane Gaillard
Journal:  Eur J Appl Physiol       Date:  2013-11-19       Impact factor: 3.078

2.  Perceptual load, voluntary attention, and aging: an event-related potential study.

Authors:  Yan Wang; Shimin Fu; Pamela Greenwood; Yuejia Luo; Raja Parasuraman
Journal:  Int J Psychophysiol       Date:  2012-01-14       Impact factor: 2.997

3.  Inhibitory Control Deficits in Individuals with Amnestic Mild Cognitive Impairment: a Meta-Analysis.

Authors:  Rahel Rabi; Brandon P Vasquez; Claude Alain; Lynn Hasher; Sylvie Belleville; Nicole D Anderson
Journal:  Neuropsychol Rev       Date:  2020-03-12       Impact factor: 7.444

4.  Inhibition in aging: What is preserved? What declines? A meta-analysis.

Authors:  Alodie Rey-Mermet; Miriam Gade
Journal:  Psychon Bull Rev       Date:  2018-10

5.  Executive function: Responses to aerobic exercise in Alzheimer's disease.

Authors:  Fang Yu; David M Vock; Terry R Barclay
Journal:  Geriatr Nurs       Date:  2017-10-12       Impact factor: 2.361

Review 6.  Neurovascular function in Alzheimer's disease patients and experimental models.

Authors:  Nektaria Nicolakakis; Edith Hamel
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-06       Impact factor: 6.200

Review 7.  Prosaccade and Antisaccade Paradigms in Persons with Alzheimer's Disease: A Meta-Analytic Review.

Authors:  Naomi Kahana Levy; Michal Lavidor; Eli Vakil
Journal:  Neuropsychol Rev       Date:  2017-10-27       Impact factor: 7.444

Review 8.  Memory suppression in Alzheimer's disease.

Authors:  Mohamad El Haj
Journal:  Neurol Sci       Date:  2015-12-23       Impact factor: 3.307

9.  Risk of Suicide Attempt in Patients With Recent Diagnosis of Mild Cognitive Impairment or Dementia.

Authors:  Mia Maria Günak; Deborah E Barnes; Kristine Yaffe; Yixia Li; Amy L Byers
Journal:  JAMA Psychiatry       Date:  2021-06-01       Impact factor: 21.596

10.  Multimodal measurement approach to identify individuals with mild cognitive impairment: study protocol for a cross-sectional trial.

Authors:  Bernhard Grässler; Fabian Herold; Milos Dordevic; Tariq Ali Gujar; Sabine Darius; Irina Böckelmann; Notger G Müller; Anita Hökelmann
Journal:  BMJ Open       Date:  2021-05-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.